$NASDAQ:QUBT Breaking Out of Bullish Pennant

NASDAQ:QUBT Looks like this is breaking out with an ~$8 upside (~$16 Price Target). Waiting for validation on volume, but we're already above 28M shares traded in the first 2 hours.

Read More

XRP Climbs 10% In Bullish Trade

- XRP was trading at $2.6368 by 05:19 (10:19 GMT) on the Index on Tuesday, up 10.30% on the day. It was the largest one-day percentage gain since...

Read More

PYPL - Another HTF Bullish Beginning Despite Probable FED Pivot

Did look weak having slumped through the demand line. But it has now made a strong recovery back above. This is a significant tide turning event I think. And so it would appear that yet again we have a 3 wave upside correction to initiate an accumulation phase... This leads to a slump. From there, the first uptrend of significance has begun. So PayPal is a nice buy here I think. It may yet slump back to re-test the demand line also if Nasdaq has a pull back. But in higher time frame, this looks to be a great buy-and-hold for long term. It is interesting this phase because we have a potential FED pivot next month which historically has led to devastating losses. But yet we are seeing quite a few stocks making their way out of accumulative structures. So we'll have to see how that plays out. But the chart on its own merit looks very good here for an entry. PayPal is still very much no.1 in online payments. So this should be a solid buy really. Not advice

Read More

AMC Stock Analysis: Poised for a Skyrocketing Rally?

AMC Entertainment Holdings (AMC) has shown intriguing market behaviour recently. Since its low of $4.03, the stock staged an upward move, peaking at $5.50. This move could be seen as corrective, but due to its correlation with GameStop (GME) and retail investor sentiment, we interpret it as an impulsive contracting diagonal wave. The subsequent drop to $4.30, marked by an ABC correction, likely served to shake out stop-loss orders. Now, AMC appears primed to surge beyond $5.50, with an initial target of $18 and the potential to climb toward $40 or more. However, our bullish scenario hinges on $4.03 remaining untouched. Breaching this level would invalidate our outlook and point to further bearish pressure. For now, AMC represents an exciting opportunity for growth, supported by technical signals and market momentum. Stay tuned for updates as this stock unfolds its next chapter!

Read More

Buy Recommendation Note for UnitedHealth Group (UNH)

Recommendation: Buy Buy Zone: $551.50 - $557.00 Target: $600.00 (Short-Term), $650.00 (Medium-Term) Rationale Strong Fundamentals: UnitedHealth Group has consistently delivered robust revenue growth driven by its diversified healthcare services and insurance offerings. Industry Leadership: As a leader in the healthcare sector, UNH benefits from its scale, market share, and innovative healthcare solutions, ensuring long-term stability. Positive Outlook: Recent developments and earnings reports indicate strong growth potential, supported by increasing demand for managed healthcare services. Valuation: Current levels provide a favorable risk-to-reward ratio for entry, with the stock trading near a key support zone. Technical Analysis The stock has shown strong support in the $551.50 - $557 range, making it an attractive buying opportunity. A breakout above $560 could signal a bullish continuation toward the target zones. Technical Analysis The stock has shown strong support in the $551.50 - $557 range, making it an attractive buying opportunity. A breakout above $560 could signal a bullish continuation toward the target zones. Disclaimer: This note is for study and informational purposes only. The recommendations and price levels mentioned are based on market observations and are not a guarantee of performance. Please consult with a licensed financial advisor and carefully consider your risk tolerance before making any investment decisions. Past performance is not indicative of future results. Investing in stocks carries inherent risks, including the potential loss of capital.

Read More

"Balanced Biotech Strategy"

Trading TNXP requires careful consideration of both the high reward potential and the significant risks involved. Combining technical analysis for short-term trades with a fundamental approach for long-term investments, while employing robust risk management techniques, can help navigate the volatile nature of this stock. Always stay informed about the latest company developments and market conditions to make well-informed decisions.

Read More

XRP Price Trapped In Consolidation: Will Bulls Break Free?

Aayush Jindal, a luminary in the world of financial markets, whose expertise spans over 15 …

Read More

NYC City Councilwoman Cabán Calls on Hochul to Remove Adams — ‘He Cannot Govern’

New York City Councilwoman Tiffany Cabán (D) said Thursday on CNN’s “The Lead” that New …

Read More

CNN turns over internal documents as part of high-stakes defamation suit

FIRST ON FOX – CNN on Thursday night handed over a batch of internal documents …

Read More

Worldcoin fined again! Crypto store clerk runs off with $500K cash: Asia Express

Worldcoin hit with $850K fine in South Korea Worldcoin Foundation and Tools for Humanity have …

Read More

Bitcoin (BTC) Back at ATH: Next Target, Dogecoin (DOGE) Volume Disappears, Ethereum (ETH) Hits $4,000, But There's a Catch

U.Today - The market leader has made a significant comeback, as Bitcoin has risen to a new all-time high of $106,000. Strong market fundamentals and increasing institutional...

Read More

Costco’s Earnings Top Estimates, But Sales Miss as Growth Slows

Key Takeaways Costco Wholesale reported fiscal fourth-quarter earnings that topped analysts’ expectations but narrowly missed …

Read More

Cattle Pops with Help from Higher Cash Trade

Switch the Market flag for targeted data from your country of choice. Open the menu …

Read More

Soybeans Fall from Highs to Close Lower

Switch the Market flag for targeted data from your country of choice. Open the menu …

Read More

Estée Lauder Stock Climbs After China Unveils Economic Stimulus

Key Takeaways Shares of beauty products maker Estée Lauder climbed 10% on Thursday, posting one …

Read More